These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Synthesis, biological evaluation and molecular modeling study of pyrazole and pyrazoline derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Part 2. El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; ElTahir KE Bioorg Med Chem; 2012 May; 20(10):3306-16. PubMed ID: 22516672 [TBL] [Abstract][Full Text] [Related]
4. Design and efficient synthesis of pyrazoline and isoxazole bridged indole C-glycoside hybrids as potential anticancer agents. Kumari P; Mishra VS; Narayana C; Khanna A; Chakrabarty A; Sagar R Sci Rep; 2020 Apr; 10(1):6660. PubMed ID: 32313038 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and Biological Evaluation of 1,3,5-Trisubstituted 2-Pyrazolines as Novel Cyclooxygenase-2 Inhibitors with Antiproliferative Activity. Vahedpour T; Kaur J; Hemmati S; Hamzeh-Mivehroud M; Alizadeh AA; Wuest F; Dastmalchi S Chem Biodivers; 2021 Mar; 18(3):e2000832. PubMed ID: 33620122 [TBL] [Abstract][Full Text] [Related]
6. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity. Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities. Ahmed AHH; Mohamed MFA; Allam RM; Nafady A; Mohamed SK; Gouda AE; Beshr EAM Bioorg Chem; 2022 Dec; 129():106171. PubMed ID: 36166898 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX. Shen FQ; Wang ZC; Wu SY; Ren SZ; Man RJ; Wang BZ; Zhu HL Bioorg Med Chem Lett; 2017 Aug; 27(16):3653-3660. PubMed ID: 28720504 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents. Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287 [TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, Molecular Docking, and Anticancer Evaluation of Pyrazole Linked Pyrazoline Derivatives with Carbothioamide Tail as EGFR Kinase Inhibitors. Nawaz F; Alam O; Perwez A; Rizvi MA; Naim MJ; Siddiqui N; Firdaus JU; Rahman S; Jha M; Sheikh AA Anticancer Agents Med Chem; 2021; 21(1):42-60. PubMed ID: 32718297 [TBL] [Abstract][Full Text] [Related]
11. Discovery of novel aminophosphonate derivatives containing pyrazole moiety as potential selective COX-2 inhibitors. Zhang B; Hu XT; Zhou KM; Yang YS; Zhu HL Bioorg Chem; 2020 Sep; 102():104096. PubMed ID: 32707279 [TBL] [Abstract][Full Text] [Related]
12. Pyrazoline analogs as potential anticancer agents and their apoptosis, molecular docking, MD simulation, DNA binding and antioxidant studies. Rana M; Arif R; Khan FI; Maurya V; Singh R; Faizan MI; Yasmeen S; Dar SH; Alam R; Sahu A; Ahmad T; Rahisuddin Bioorg Chem; 2021 Mar; 108():104665. PubMed ID: 33571809 [TBL] [Abstract][Full Text] [Related]
13. Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents. Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM Eur J Med Chem; 2013 Jul; 65():70-82. PubMed ID: 23693151 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents. Abolhasani H; Zarghi A; Komeili Movahhed T; Abolhasani A; Daraei B; Dastmalchi S Bioorg Med Chem; 2021 Feb; 32():115960. PubMed ID: 33477020 [TBL] [Abstract][Full Text] [Related]
15. Ligand based design and synthesis of pyrazole based derivatives as selective COX-2 inhibitors. Murahari M; Mahajan V; Neeladri S; Kumar MS; Mayur YC Bioorg Chem; 2019 May; 86():583-597. PubMed ID: 30782576 [TBL] [Abstract][Full Text] [Related]
16. Design and biological evaluation of novel hybrids of 1, 5-diarylpyrazole and Chrysin for selective COX-2 inhibition. Ren SZ; Wang ZC; Zhu XH; Zhu D; Li Z; Shen FQ; Duan YT; Cao H; Zhao J; Zhu HL Bioorg Med Chem; 2018 Aug; 26(14):4264-4275. PubMed ID: 30031652 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors. Sever B; Altıntop MD; Radwan MO; Özdemir A; Otsuka M; Fujita M; Ciftci HI Eur J Med Chem; 2019 Nov; 182():111648. PubMed ID: 31493743 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of N-substituted-3,5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors. Fioravanti R; Bolasco A; Manna F; Rossi F; Orallo F; Ortuso F; Alcaro S; Cirilli R Eur J Med Chem; 2010 Dec; 45(12):6135-8. PubMed ID: 20974503 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy. Ren SZ; Wang ZC; Zhu D; Zhu XH; Shen FQ; Wu SY; Chen JJ; Xu C; Zhu HL Eur J Med Chem; 2018 Sep; 157():909-924. PubMed ID: 30149323 [TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 and 15-lipoxygenase inhibition, synthesis, anti-inflammatory activity and ulcer liability of new celecoxib analogues: Determination of region-specific pyrazole ring formation by NOESY. Abdelall EKA; Lamie PF; Ali WAM Bioorg Med Chem Lett; 2016 Jun; 26(12):2893-2899. PubMed ID: 27158139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]